Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1

Journal of Peptide Science

Volumn 15, Issue 9, 2009, Pages 569-575

  Zhu, Wan Long ^a   Hahm, Kyung Soo ^a,b   Shina, Song Yub ^a,b  

^a Chosun University   (South Korea)

^b Chosun University College of Medicine   (South Korea)

Author keywords

Antimicrobial peptide; Cell selectivity; Cell penetrating peptide; Mechanism of action; Pep 1; Pep 1 K

Indexed keywords

CALCEIN; INDOLICIDIN; LYSYLLYSYLPROLYLTRYPTOPHANYLTRYPTOPHANYLLYSYLPROLYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTRYPTOPHANYLLYSYLLYSYL; LYSYLLYSYLTHREONYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTHREONYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTRYPTOPHANYL; LYSYLLYSYLTHREONYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTHREONYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTRYPTOPHANYLLYSYLLYSYL; LYSYLLYSYLTHREONYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTHREONYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTRYPTOPHANYLSERYLGLUTAMYLPROLYL; LYSYLLYSYLTHREONYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTHREONYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTRYPTOPHANYLSERYLGLUTAMYLPROLYLLYSYLLYSYL; LYSYLLYSYLTHREONYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTHREONYLTRYPTOPHANYLTRYPTOPHANYLLYSYLTRYPTOPHANYLSERYLGLUTAMYLPROLYLLYSYLLYSYLLYSYLARGINYLLYSYLVALINYL; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIMICROBIAL ACTIVITY; CELL MEMBRANE POTENTIAL; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DESIGN; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CELL MEMBRANE; CELLS, CULTURED; CIRCULAR DICHROISM; CYSTEAMINE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDES; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 70349636911     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1145     Document Type: Conference Paper

References (37)

1. Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier for the delivery of bilogically active proteins into mammalian cells. Nat. Biotechnol. 2001; 19: 1143-1147.
2. Henriques ST, Castanho MARB. Consequences of nonlytic membrane perturbation to the translocation of the cell penetrating peptide pep-1 in lipidic vesicles. Biochemistry 2004; 43: 9716-9724.
3. Henriques ST, Costa J, Castanho MA. Translocation of betagalactosidase mediated by the cell-penetrating peptide pep-1 into lipid vesicles and human HeLa cells is driven by membrane electrostatic potential. Biochemistry 2005; 44: 10189-10198.
4. Nekhotiaeva N, Elmquist A, Rajarao GK, Hällbrink M, Langel U, Good L. Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J. 2004; 18: 394-396.
5. Henriques ST, Melo MN, Castanho MA. Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem. J. 2006; 399: 1-7.
6. Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem. Biophys. Res. Commun. 2006; 349: 769-774.
7. Steffen H, Rieg S, Wiedemann I, Kalbacher H, Deeg M, Sahl HG, Peschel A, Götz F, Garbe C, Schittek B. Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob. Agents Chemother. 2006; 50: 2608-2620.
8. Zhu WL, Lan H, Park Y, Yang ST, Kim JI, Park IS, You HJ, Lee JS, Park YS, Kim Y, Hahm KS, Shin SY. Effects of Pro→peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide. Biochemistry 2006; 45: 13007-13017.
9. Song YM, Park Y, Lim SS, Yang ST, Woo ER, Park IS, Lee JS, Kim JI, Hahm KS, Kim Y, Shin SY. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Biochemistry 2005; 44: 12094-12106.
10. Mao D, Wallace BA. Differential light scattering and absorption flattening optical effects are minimal in the circular-dichroism spectra of small unilamellar vesicles. Biochemistry 1984; 23: 2667-2673.
11. Shai Y, Bach D, Yanovsky A. Channel formation properties of synthetic pardaxin and analogues. J. Biol. Chem. 1990; 265: 20202-20209.
12. De Kroon AI, Soekarjo MW, De Gier J, De Kruijff B. The role of charge and hydrophobicity in peptide-lipid interaction: a comparative study based on tryptophan fluorescence measurements combined with the use of aqueous and hydrophobic quenchers. Biochemistry 1990; 29: 8229-8240.
13. Zhao H, Kinnunen PK. Binding of the antimicrobial peptide temporin L to liposomes assessed by Trp fluorescence. J. Biol. Chem. 2002; 277: 25170-25177.
14. Eftink MR, Ghiron CA. Exposure of tryptophanyl residues in proteins. Quantitative determination by fluorescence quenching studies. Biochemistry 1976; 15: 672-680.
15. Eftink MR, Ghiron CA. Fluorescence quenching of indole and model micelle systems. J. Phys. Chem. 1976; 80: 486-493.
16. Barlett CR. Phosphorus assay in column chromatography. J. Biol. Chem. 1959; 234: 466-468.
17. Friedrich CL, Moyles D, Beveridge TJ, Hancock RE. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 2000; 44: 2086-2092.
18. Friedrich CL, Rozek A, Patrzykat A, Hancock RE. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J. Biol. Chem. 2001; 276: 24015-24022.
19. Zhu WL, Hahm KS, Shin SY. Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action. J. Pept. Sci. 2007; 13: 529-535.
20. Ryge TS, Doisy X, Ifrah D, Olsen JE, Hansen PR. New indolicidin analogues with potent antibacterial activity. J. Pept. Sci. 2004; 64: 171-185.
21. Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS. Rational design of a-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005; 280: 12316-12329.
22. Fazio MA, Jouvensal L, Vovelle F, Bulet P, Miranda MT, Daffre S, Miranda A. Biological and structural characterization of new linear gomesin analogues with improved therapeutic indices. Biopolymers 2007; 88: 386-400.
23. Zhu WL, Song YM, Park Y, Park KH, Yang ST, Kim JI, Park IS, Hahm KS, Shin SY. Substitution of the leucine zipper sequence inmelittin with peptoid residues affects self-association, cell selectivity, and mode of action. Biochim. Biophys. Acta 2007; 1768: 1506-1517.
24. Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 1998; 244: 253-257.
25. Park CB, Yi KS, Matsuzaki K, Kim MS, Kim SC. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. U S A. 2000; 97: 8245-8250.
26. Kobayashi S, Chikushi A, Tougu S, Imura Y, Nishida M, Yano Y, Matsuzaki K. Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry 2004; 43: 15610-15616.
27. Ladokhin AS, Selsted ME, White SH. Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids. Biophys. J. 1997; 72: 794-805.
28. Ladokhin AS, Selsted ME, White SH. CD spectra of indolicidin antimicrobial peptides suggest turns, not polyproline helix. Biochemistry 1999; 38: 12313-12319.
29. Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K. Antimicrobial activity of a 13 amino acid tryptophanrich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides. FEBS Lett. 1996; 390: 95-98.
30. Chan DI, Prenner EJ, Vogel HJ. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 2006; 1758: 1184-1202.
31. Schibli DJ, Epand RF, Vogel HJ, Epand RM. Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. Biochem. Cell Biol. 2002; 80: 667-677.
32. Subbalakshmi C, Bikshapathy E, Sitaram N, Nagaraj R. Antibacterial and hemolytic activities of single tryptophan analogs of indolicidin. Biochem. Biophys. Res. Commun. 2000; 274: 714-716.
33. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1998; 1376: 391-400.
34. Heller WT, Waring AJ, Lehrer RI, Harroun TA, Weiss TM, Yang L, Huang HW. Membrane thinning effect of the β-sheet antimicrobial protegrin. Biochemistry 2000; 39: 139-145.
35. Marassi FM, Opella SJ, Juvvadi P, Merrifield RB. Orientation of cecropin A helices in phospholipid bilayers determined by solid-state NMR spectroscopy. Biophys. J. 1999; 77: 3152-3155.
36. Gennaro R, Zanetti M, Benincasa M, Podda E, Miani M. Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr. Pharm. Des. 2002; 8: 763-778.
37. Park KH, Park Y, Park IS, Hahm KS, Shin SY. Bacterial selectivity and plausible mode of antibacterial action of designed Pro-rich short model antimicrobial peptides. J. Pept. Sci. 2008; 14: 876-882.